Why Nabota Is Winning Global Trust: Over KRW 1 Trillion in Cumulative Sales

A Global Milestone for Nabota

Nabota has officially surpassed KRW 1 trillion in cumulative sales, marking a major milestone not only for the brand but also for the Korean medical aesthetics industry. This achievement reflects years of continuous innovation, strict quality control, and successful expansion into international markets. Today, Nabota is distributed across numerous countries and has earned the trust of aesthetic clinics and medical professionals worldwide.

According to Yoon Jun-soo, Head of the Nabota Business Division at Daewoong Pharmaceutical, the company’s long-term vision extends far beyond this milestone.

“The KRW 1 trillion cumulative sales milestone is the result of Nabota’s quality competitiveness and global market strategy. Through continued global expansion and the development of a next-generation aesthetics portfolio, we aim to grow Nabota into a global blockbuster brand with annual sales of KRW 500 billion by 2030.”

This statement highlights Daewoong Pharmaceutical’s commitment to strengthening its presence in the global aesthetics market through continuous research, product development, and strategic partnerships. Rather than focusing solely on domestic success, the company has consistently invested in international regulatory approvals, physician education, and market expansion, allowing Nabota to become one of Korea’s most recognized botulinum toxin brands worldwide.

Why Are More Clinics Choosing Nabota?

The rapid growth of Nabota is driven by far more than impressive sales figures. Around the world, aesthetic clinics increasingly prioritize products that deliver consistent clinical performance, predictable outcomes, and high manufacturing standards. Nabota has established a strong reputation by meeting these expectations while maintaining strict quality control throughout its production process.

One of Nabota’s most notable advantages is its formulation. Unlike some older-generation botulinum toxin products, Nabota does not contain animal-derived proteins. By eliminating these components, the formulation may help reduce the potential risk of allergic reactions associated with animal-derived ingredients, providing greater confidence for both practitioners and patients.

In addition, Nabota is manufactured using advanced purification technology and rigorous quality management systems. Every production batch undergoes comprehensive testing to ensure consistency in potency, purity, and safety before reaching the market. This level of quality assurance is particularly important for physicians, as reliable products contribute to more predictable treatment outcomes and greater patient satisfaction.

Another factor behind Nabota’s growing popularity is its versatility. It is widely used for facial wrinkle treatments and various aesthetic procedures, making it a practical option for clinics seeking dependable performance across different treatment protocols. As demand for minimally invasive procedures continues to rise globally, products with proven reliability and consistent quality are becoming increasingly valuable.

Trusted Quality, Proven Worldwide

The global medical aesthetics market continues to experience rapid growth, driven by increasing patient demand for non-surgical cosmetic treatments. In this competitive environment, healthcare professionals are placing greater emphasis on products supported by scientific research, regulatory approvals, and long-term clinical experience.

Surpassing KRW 1 trillion in cumulative sales represents far more than commercial success. It reflects years of trust built between Nabota and thousands of clinics, physicians, and healthcare professionals around the world. Sustained sales growth on this scale is possible only when a product consistently meets the expectations of both practitioners and patients.

Looking ahead, Daewoong Pharmaceutical plans to further strengthen Nabota’s global competitiveness by expanding into new markets, investing in next-generation aesthetic solutions, and broadening its product portfolio. As innovation continues to shape the aesthetics industry, Nabota is well positioned to remain one of the leading Korean botulinum toxin brands on the international stage.

With its combination of advanced manufacturing, consistent product quality, growing global presence, and commitment to innovation, Nabota continues to reinforce its reputation as a trusted choice for aesthetic professionals seeking safe, reliable, and high-quality treatment solutions. As the global aesthetic industry continues to evolve, Nabota remains committed to delivering quality, innovation, and confidence to clinics and patients around the world.